Publishing research using ab9957? Please let us know so that we can cite the reference in this datasheet.

ab9957 has been referenced in 14 publications.

  • Scotto di Carlo F  et al. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location. BMC Cancer 18:358 (2018). PubMed: 29609578
  • Maria S  et al. Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures. Aging (Albany NY) 9:256-285 (2017). PubMed: 28130552
  • Takegami N  et al. RANK/RANKL/OPG system in the intervertebral disc. Arthritis Res Ther 19:121 (2017). PubMed: 28576140
  • Divisato G  et al. The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences. Oncotarget 8:63121-63131 (2017). PubMed: 28968976
  • Beier EE  et al. Elevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent Mice. Toxicol Sci 149:277-88 (2016). PubMed: 26518054
  • Li XJ  et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-?B signaling pathways in osteoprotegerin knockout mice. Int J Mol Med N/A:N/A (2016). WB ; Mouse . PubMed: 27840967
  • He M  et al. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. Mol Med Rep 14:1054-60 (2016). IHC-P ; Mouse . PubMed: 27277157
  • Yamagishi T  et al. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors. PLoS One 11:e0154680 (2016). IHC . PubMed: 27163152
  • Terasawa K  et al. Preferential recognition of isocitrate dehydrogenase by a rabbit monoclonal antibody (ab124797) against the C-terminal peptide of RANKL. J Immunol Methods N/A:N/A (2015). PubMed: 25771969
  • Szwarc MM  et al. Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors. PLoS One 10:e0128467 (2015). WB ; Mouse . PubMed: 26061636
  • Irie K  et al. Impact of the Oral Commensal Flora on Alveolar Bone Homeostasis. J Dent Res 93:801-806 (2014). PubMed: 24935067
  • Peng X  et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. PLoS One 8:e58361 (2013). WB, IHC-P ; Human . PubMed: 23516466
  • Mediero A  et al. Adenosine A2A receptor activation prevents wear particle-induced osteolysis. Sci Transl Med 4:135ra65 (2012). IHC-P ; Mouse . PubMed: 22623741
  • Ndip A  et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes 60:2187-96 (2011). IHC-P ; Human . PubMed: 21659498

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up